Status:
COMPLETED
Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)
Lead Sponsor:
GlaxoSmithKline
Conditions:
Heart Failure, Congestive
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
This program is designed to improve medical care and education of hospitalized patients with heart failure and accelerate the initiation of evidence-based heart failure guideline recommended therapies...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Hospitalized for episode of worsening heart failure as primary cause of admission or significant heart failure symptoms that develop during the hospitalization when the initial reason for admission was not heart failure.
- Systolic dysfunction (LVEF \< 40%) or heart failure symptoms in the setting of preserved systolic function (diastolic dysfunction).
- Exclusion criteria:
- This study has no exclusion criteria.
Exclusion
Key Trial Info
Start Date :
December 16 2002
Trial Type :
INTERVENTIONAL
End Date :
June 30 2005
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT00344513
Start Date
December 16 2002
End Date
June 30 2005
Last Update
November 24 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.